Smith & Nephew to pay $11 million in whistleblower suit
Reuters
Published Sep 04, 2014 21:42
Smith & Nephew to pay $11 million in whistleblower suit
By Brendan Pierson
(Reuters) - London-based medical device maker Smith & Nephew PLC (L:SN) has agreed to pay $11.3 million (6.9 million pounds) to settle allegations that it sold the U.S. government devices it claimed were U.S.-made but actually came from Malaysia.
The settlement was filed Wednesday in Tennessee federal court, ending a whistleblower lawsuit brought in 2008 by a former Smith & Nephew information technology manager, Samuel Cox. Cox will get $2.3 million, the government $6 million, and $3 million will go towards attorneys' fees, according to the settlement.
Under U.S. law, whistleblowers are entitled to a share of a successful recovery.
Cox claimed that Smith & Nephew violated the federal Trade Agreements Act, which requires contractors to sell the government products made either in the United States or in countries it has signed agreements with.
In 2007 and 2008, Smith & Nephew sold the Department of Veterans Affairs orthopaedic devices that it had bought from Malaysia-based Straits Orthopaedics while claiming they were made in the United States, according to the lawsuit. Malaysia does not have a trade agreement with the United States.
The U.S. government did not intervene in the suit but joined in negotiating the settlement earlier this year, according to H. Vincent McKnight of Sanford Heisler, an attorney for Cox.
The case is the first whistleblower settlement involving false country of origin claims for medical devices, according to a press release from Sanford.
"Today's settlement sends a clear message to those medical device companies that routinely violate the Trade Agreements Act by misrepresenting the 'Country of Origin' of goods sold under contract to U.S. Government agencies," McKnight said in a statement.
Smith & Nephew did not immediately return a request for comment.
The case is United States ex rel. Cox v. Smith & Nephew, U.S. District Court for the Western District of Tennessee, No. 2:08-cv-02832.
(Reporting By Brendan Pierson; Editing by Ted Botha, Bernard Orr)
Get The App
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.